Allogeneic iNKT Cell Therapy (agenT-797) After SCT

Clinical trial NCT07758218 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07758218
Sponsor: University of Wisconsin, Madison
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Allogenic Stem Cell Transplantation Myeloid Malignancies Lymphoid Malignancies Acute Myeloid Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2026-10-01
Primary completion: 2029-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.